FATE FY 2016 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FATEFate Therapeutics, Inc.

$142M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+81.1% YoY

Gross Profit

-$22M-500.9% margin

Operating Income

-$32M-726.1% margin

Net Income

-$33M-760.2% margin

EPS (Diluted)

$-1.05

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$95M

Total Liabilities

$22M

Stockholders' Equity

$73M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+81.1%
Gross Profit	-$22M	-$17M	-26.5%
Operating Income	-$32M	-$28M	-15.0%
Net Income	-$33M	-$30M	-11.6%